Biorefineries outlines the processes and steps to successfully scale up production of two types of biofuels, butanol and ethanol, from cellulosic residues for commercial purposes. It covers practical topics, including biomass availability, pretreatment, fermentation, and water recycling, as well as policy and economic factors. This reflects the unique expertise of the editor team, whose backgrounds range from wood and herbaceous feedstocks to process economics and industrial expertise. The strategies presented in this book help readers to design integrated and efficient processes to reduce the cost of production and achieve an economically viable end product
Table of Contents
PART I CELLULOSIC BIOMASS PROCESSING & BIOREFINERY ROAD MAP
CHAPTER 1 An Overview of Existing Individual Unit Operations
CHAPTER 2 Biomass for Biorefining: Resources, Allocation, Utilization, and Policies
CHAPTER 3 Biorefinery Roadmaps
CHAPTER 4 Integration of (Hemi)-Cellulosic Biofuels Technologies with Chemical Pulp Production
CHAPTER 5 Integrated Processes for Product Recovery
PART II CELLULOSIC ETHANOL
CHAPTER 6 Development of Growth-Arrested Bioprocesses with Corynebacterium glutamicum for Cellulosic Ethanol Production from Complex Sugar Mixtures
CHAPTER 7 Consolidated Bioprocessing for Ethanol Production
CHAPTER 8 Integration of Ethanol Fermentation with Second Generation Biofuels Technologies
PART III CELLULOSIC BUTANOL
CHAPTER 9 Mixed Sugar Fermentation by Clostridia and Metabolic Engineering for Butanol Production
CHAPTER 10 Integrated Bioprocessing and Simultaneous Product Recovery for Butanol Production
CHAPTER 11 Integrated Production of Butanol from Glycerol
PART IV PROCESS ECONOMICS & FARM-BASED BIOREFINERY
CHAPTER 12 Process Economics of Renewable Biorefineries: Butanol and Ethanol Production in Integrated Bioprocesses from Lignocellulosics and Other Industrial By-Products
CHAPTER 13 Integrated Farm-Based Biorefinery
Authors
Nasib Qureshi USDA-ARS-NCAUR, IL, USA. Affiliate Faculty, Institute for Genomic Biology, University of Illinois at Urbana-Champaign (UIUC), IL, USA (2004-2011). Adjunct Professor, UIUC (Biochemical Engineering, 2003-2018).. Research Chemical/Biochemical Engineer, United States Department of Agriculture (USDA), Agricultural Research Service (ARS), National Center for Agricultural Utilization Research (NCAUR), Peoria, IL, USA. PhD (Chemical/Biological Engineering), PhD (Fermentation Technology) Fellow in American Institute of Chemical Engineers (AIChE), Society for Industrial Microbiology & Biotechnology (SIMB), and American Institute of Chemists (AIC). Co-Editor, Stem cells in Regenerative Medicine (Wiley, 2015) David Hodge Department of Chemical & Biological Engineering, Montana State University, Bozeman, MT. Michigan State University, MI USA Alain Vertes NxR Biotechnologies GmbH, Basel, Switzerland. University of Illinois at Urbana-Champaign, Institut Pasteur Paris, and University of Lille Flanders-Artois. Sloan Fellow from London Business School and a microbiologist by training (University of Illinois at Urbana-Champaign, Institut Pasteur Paris, and University of Lille Flandres-Artois).
. Consulting, Partnering & Fund Raising, Founder, Managing Director, NxR Biotechnologies, Switzerland.
. Dr. Vertès is a strategy and business development consultant for cell therapeutic biotech companies, and works to enable seed funding in the field. Focusing on technology deployment and innovation commercialization, he has contributed to both industrial and pharmaceutical biotechnology, in different functions including research, manufacturing, contract research, and strategic alliances in pharmaceuticals (Lilly, Pfizer, Roche).
. Championed radical innovation for bringing to patients disease-modifying, paradigm-changing therapeutics such as siRNA, and led in a scientific and business manner Roche's global cell therapeutics strategy and implementation team resulting in Roche's entry in 2010 in the field of regenerative medicine.
. Member, Industry Committee-Europe, Tissue Engineering and Regenerative Medicine International Society
. Co-Editor, Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies (Wiley, 2015).
